Los Angeles Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.36M | Sell |
|
|||||
|
2025
Q2 | $1.41M | Sell |
|
|||||
|
2025
Q1 | $2.36M | Buy |
|
|||||
|
2024
Q4 | $2.1M | Buy |
|
|||||
|
2024
Q3 | $681K | Sell |
|
|||||
|
2024
Q2 | $828K | Sell |
|
|||||
|
2024
Q1 | $1.25M | Buy |
|
|||||
|
2023
Q4 | $2.04M | Buy |
|
|||||
|
2023
Q3 | $944K | Buy |
|
|||||
|
2023
Q2 | $995K | Buy |
|
|||||
|
2023
Q1 | $479K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $425K | Sell |
|
|||||
|
2020
Q4 | $2.19M | Sell |
|
|||||
|
2020
Q3 | $1.9M | Sell |
|
|||||
|
2020
Q2 | $3.77M | Buy |
|
|||||
|
2020
Q1 | $2.76M | Buy |
|
|||||
|
2019
Q4 | $1.93M | Buy |
|
|||||
|
2019
Q3 | $1.49M | Buy |
|
|||||
|
2019
Q2 | $420K | Sell |
|
|||||
|
2019
Q1 | $887K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $6.88M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $416K | Buy |
|